Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.650
+0.150 (10.00%)
Jun 25, 2025, 1:57 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $273.94 million as of June 26, 2025. Its market cap has decreased by -71.73% in one year.
Market Cap
273.94M
Enterprise Value
137.46M
Revenue
27.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.65
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 273.94M, a decrease of -49.12%. That is a compound annual growth rate of -13.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 26, 2025 | 261.66M | -19.45% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.59B |
Elite Pharmaceuticals | 801.20M |
Veradigm | 762.54M |
Nika Pharmaceuticals | 708.22M |
Tian'an Technology Group | 637.25M |
American Oncology Network | 446.28M |
CytoDyn | 386.66M |
Glass House Brands | 378.93M |